A drug that could help thousands of multiple sclerosis (MS) patients walk more easily is now being offered on the NHS in England. The medication, called fampridine, works by boosting nerve signals, making it simpler for patients to move. According to reports, up to 5,000 people could be eligible for this treatment.
MS is a chronic condition that affects the central nervous system, often causing problems with movement and coordination. For many patients, walking can become difficult. Fampridine is not a cure, but it can improve mobility by enhancing the transmission of signals along nerves. Doctors describe it as a "life-changing" option for those who respond well.
The drug has been approved for use on the NHS after assessments showed it can significantly improve walking speed in some patients. Treatment is given as a tablet, and patients are monitored to see if it works for them. If it does not show benefit after a few weeks, it is stopped.
This development brings new hope for many living with MS, especially those who have struggled with walking. The NHS aims to make the drug available to eligible patients across England, though availability may vary by region. Patients interested in fampridine should speak to their specialist about whether they might benefit.